Home Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
Article Open Access

Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus

  • Jun Yao , Jiaying Pan , Qiaoying Jiang , Hui Wang and Yiqi Zhao EMAIL logo
Published/Copyright: December 31, 2024

Abstract

Gestational diabetes mellitus (GDM) is a common metabolic disorder during pregnancy characterized by glucose intolerance, which poses risks to both maternal and fetal health. Baicalein, a flavonoid derived from the roots of Scutellaria baicalensis Georgi, exhibits various biological functions and has been implicated in the modulation of several diseases. However, the regulatory effects and underlying mechanisms of Baicalein in GDM progression remain unclear. In this study, we found that Baicalein ameliorates metabolic disturbances in GDM mice by improving glucose tolerance, insulin sensitivity, fasting blood glucose levels, and plasma insulin levels. Additionally, Baicalein treatment positively impacted litter size and birth weight. GDM mice exhibited increased inflammation and oxidative stress, which were mitigated following Baicalein administration (40 mg/kg). Furthermore, elevated protein levels of NLRP3, IL-1β, and IL-18 observed in GDM mice were reduced by Baicalein treatment. In conclusion, Baicalein inhibits the NLRP3 inflammasome and alleviates placental inflammation and oxidative stress associated with GDM. These findings provide valuable insights into the potential therapeutic role of Baicalein in managing GDM.

1 Introduction

Gestational diabetes mellitus (GDM) is a prevalent metabolic disorder that occurs during pregnancy, characterized by glucose intolerance that typically manifests in the second and third trimesters [1]. This condition is associated with several adverse outcomes, including abnormal embryonic development, insulin resistance, hyperinsulinemia, and hyperglycemia [2]. The incidence of GDM has been rising, primarily due to increasing maternal obesity and advanced maternal age [3]. GDM significantly increases the risk of severe complications for both mother and infant, such as macrosomia, dystocia, and neonatal hypoglycemia [4]. Despite ongoing research, the pathogenesis of GDM remains incompletely understood. Known etiological factors include oxidative stress, insulin resistance, and inflammation, which are triggered by placental hormones and strongly linked to the progression of GDM [5]. Therefore, the identification of novel and effective therapeutic agents is critical for managing GDM.

Baicalein is a flavonoid compound extracted from the roots of Scutellaria baicalensis Georgi, known for its diverse pharmacological effects [6]. Recent studies have revealed various biological functions of Baicalein, including its role in regulating different diseases. For instance, Baicalein can alleviate oxidative stress and promote autophagy, and was shown to improve cardiac hypertrophy in mice [7]. Additionally, Baicalein targets the GPX4/ACSL4/ACSL3 axis to inhibit ferroptosis, thereby reducing cerebral ischemia-reperfusion injury [8]. In hyperlipidemic pancreatitis, Baicalein modulates the miR-192-5p/TXNIP axis to inhibit the NLRP3/Caspase-1 pathway, thereby mitigating pyroptosis and inflammation [9]. Moreover, Baicalein regulates the AhR/IL-22 pathway to enhance the intestinal epithelial barrier, which alleviates ulcerative colitis [10]. Notably, Baicalein has been shown to target the miR-17-5p-Mfn1/2-NF-κB pathway in trophoblast cells, reducing high glucose-induced inflammation and apoptosis [11]. Despite these findings, the regulatory effects and mechanisms of Baicalein in GDM progression in vivo remain unexplored.

In this study, we demonstrate that Baicalein inhibits the NLRP3 inflammasome and alleviates placental inflammation and oxidative stress in a GDM mouse model, suggesting that Baicalein holds potential as a therapeutic agent for managing GDM.

2 Materials and methods

2.1 Animal model

C57BL/KsJ+/+ (wild-type) and C57BL/KsJdb/+ (db/+) mice (10 weeks old, n = 24 per sex) were obtained from the Nanjing Model Animal Center (Nanjing, China). All animal procedures were conducted in accordance with the guidelines of the Ethics Committee of Zhejiang Provincial People’s Hospital. Female mice were individually paired with male mice of the same genotype. The presence of copulatory plugs the following morning was used to confirm mating and designate gestation day (GD) 0. Pregnant female mice were then divided into four groups: Control (normal pregnancy, C57BL/KsJ+/+), GDM (C57BL/KsJdb+ (db/+) mice treated with DMSO), GDM + 20 mg/kg Baicalein (C57BL/KsJdb+ (db/+) mice treated with 20 mg/kg Baicalein), and GDM + 40 mg/kg Baicalein (C57BL/KsJdb+ (db/+) mice treated with 40 mg/kg Baicalein). Each group consisted of six mice. Baicalein (98% purity, S25956, Shanghai Yuanye Bio-Technology Co., Ltd, Shanghai, China) was dissolved in DMSO and administered orally at doses of 20 or 40 mg/kg daily for 20 days starting from pregnancy. On GD 10, glucose and insulin tolerance were assessed using intraperitoneal glucose tolerance tests (IPGTT) and intraperitoneal insulin tolerance tests (IPITT). On GD 20, fasting blood glucose levels were measured with a glucometer (Roche Diagnostics, Risch-Rotkreuz, Switzerland), and insulin levels were quantified using an Ultra-Sensitive Mouse Insulin ELISA kit (ALPCO Diagnostics, Salem, NH). Cesarean sections were performed on GD 20 to collect placentas and fetuses for further analysis. Litter size and birth weight were recorded.

  1. Ethical approval: The research related to animal use has been complied with all the relevant national regulations and institutional policies for the care and use of animals, and has been approved by the Experimental Animal Welfare Ethics Committee of Zhejiang Provincial People’s Hospital (Approval no. 2021020).

2.2 Detection of glucose and insulin tolerance

For the IPGTT, after a 6 h fast, the mice received an intraperitoneal injection of glucose (2.0 g/kg). Blood glucose levels were measured at 0, 30, 60, 90, and 120 min using an ACCU-CHEK Advantage glucometer (Roche Diagnostics, Risch-Rotkreuz, Switzerland).

For the IPITT, after a 6 h fast, insulin (0.75 U/kg) was administered intraperitoneally. Blood glucose levels were then measured at 0, 30, 60, 90, and 120 min.

2.3 ELISA

The levels of TNF-α (ab208348, Abcam, Shanghai, China), IL-1β (ab197742), and IL-6 (ab222503) were quantified using commercial ELISA kits according to the manufacturer’s protocols.

2.4 Detection of oxidative stress

Oxidative stress markers, including malondialdehyde (MDA, ab118970, Abcam, Shanghai, China), glutathione (GSH, ab65322), myeloperoxidase (MPO, ab105136), and superoxide dismutase (SOD, ab65354), were measured using commercial kits in placental tissue samples.

2.5 Western blot

Proteins from mice placental tissues were extracted using RIPA lysis buffer (Thermo Fisher Scientific, Inc.), separated using 10% SDS-PAGE, and transferred to PVDF membranes (Beyotime, Shanghai, China). After blocking, membranes were incubated with primary antibodies at 4°C for 12 h. Secondary antibodies (1:2,000; ab7090) were then applied. Protein detection was performed using a chemiluminescence detection kit (Thermo Fisher Scientific, Inc.).

The primary antibodies used in this study were as follows: NLRP3 (1:1,000; ab263899; Abcam, Shanghai, China), IL-1β (1:1,000; ab283818), IL-18 (0.5 µg/mL; ab191860), and β-actin (1:2,000; ab8227).

2.6 Statistical analysis

Data are presented as mean value ± standard deviation (SD) and analyzed using GraphPad Prism 9 (GraphPad Inc, La Jolla, CA, USA). Comparisons were performed using one-way analysis of variance with Tukey’s post hoc test. A p-value < 0.05 was considered statistically significant.

3 Results

3.1 Baicalein improves metabolic symptoms in GDM mice

Our results showed that the glucose tolerance in GDM mice was impaired, but this impairment could be reversed using Baicalein (40 mg/kg) (Figure 1a). Similarly, insulin tolerance was reduced in GDM mice, and similarly, this reduction could be mitigated using Baicalein (40 mg/kg) (Figure 1b). Additionally, fasting blood glucose and plasma insulin levels were elevated in GDM mice, and these elevations could be normalized following Baicalein (40 mg/kg) treatment (Figure 1c and d). Overall, our findings indicate that Baicalein could improve metabolic symptoms in GDM mice.

Figure 1 
                  Baicalein ameliorates metabolic symptoms in GDM mice. The mice were divided into four groups: Control, GDM, GDM + 20 mg/kg Baicalein, and GDM + 40 mg/kg Baicalein. (a) Glucose tolerance was assessed using the IPGTT. (b) Insulin tolerance was evaluated via the IPITT. (c) Measurements of fasting blood glucose levels. (d) Assessment of plasma insulin levels. *p < 0.05, ***p < 0.001.
Figure 1

Baicalein ameliorates metabolic symptoms in GDM mice. The mice were divided into four groups: Control, GDM, GDM + 20 mg/kg Baicalein, and GDM + 40 mg/kg Baicalein. (a) Glucose tolerance was assessed using the IPGTT. (b) Insulin tolerance was evaluated via the IPITT. (c) Measurements of fasting blood glucose levels. (d) Assessment of plasma insulin levels. *p < 0.05, ***p < 0.001.

3.2 Baicalein enhances reproductive outcomes in GDM mice

In the GDM group, the number of offspring per litter was reduced, but this reduction was alleviated by Baicalein (40 mg/kg) treatment (Figure 2a). Furthermore, the birth weight of the offspring was increased in the GDM group; this effect was attenuated with Baicalein (40 mg/kg) administration (Figure 2b). Thus, Baicalein positively influenced reproductive outcomes in GDM mice.

Figure 2 
                  Baicalein improves litter size and birth weight in GDM mice. The mice were assigned to the following groups: Control, GDM, GDM + 20 mg/kg Baicalein, and GDM + 40 mg/kg Baicalein. (a) Recording of the litter size. (b) Measurements of birth weight. Statistical significance: *p < 0.05, ***p < 0.001.
Figure 2

Baicalein improves litter size and birth weight in GDM mice. The mice were assigned to the following groups: Control, GDM, GDM + 20 mg/kg Baicalein, and GDM + 40 mg/kg Baicalein. (a) Recording of the litter size. (b) Measurements of birth weight. Statistical significance: *p < 0.05, ***p < 0.001.

3.3 Baicalein reduces inflammation and oxidative stress in GDM mice

ELISA results showed that levels of IL-6, IL-1β, and TNF-α were elevated in GDM mice, but these increases were significantly reduced following Baicalein (40 mg/kg) treatment (Figure 3a). Additionally, markers of oxidative stress, including MDA and MPO, were elevated, while SOD and GSH levels were decreased in GDM mice. Baicalein (40 mg/kg) treatment normalized these oxidative stress markers (Figure 3b). Taken together, these findings indicate that Baicalein could effectively alleviate inflammation and oxidative stress in GDM mice.

Figure 3 
                  Baicalein reduces inflammation and oxidative stress in GDM mice. The mice were categorized into the Control, GDM, GDM + 20 mg/kg Baicalein, and GDM + 40 mg/kg Baicalein groups. (a) Levels of IL-6, IL-1β, and TNF-α were quantified using ELISA. (b) The levels of MDA, SOD, MPO, and GSH were assessed with commercial kits. Statistical significance: **p < 0.01, ***p < 0.001.
Figure 3

Baicalein reduces inflammation and oxidative stress in GDM mice. The mice were categorized into the Control, GDM, GDM + 20 mg/kg Baicalein, and GDM + 40 mg/kg Baicalein groups. (a) Levels of IL-6, IL-1β, and TNF-α were quantified using ELISA. (b) The levels of MDA, SOD, MPO, and GSH were assessed with commercial kits. Statistical significance: **p < 0.01, ***p < 0.001.

3.4 Baicalein attenuates NLRP3 inflammasome activation in placentae of GDM mice

NLRP3 protein expression was elevated in the placentae of GDM mice, but this elevation was reduced following Baicalein (40 mg/kg) treatment (Figure 4a). Similarly, levels of IL-1β and IL-18 were increased in GDM mice, but these increases were diminished after Baicalein (40 mg/kg) administration (Figure 4b). Collectively, Baicalein decreased NLRP3 inflammasome activation in the placentae of GDM mice.

Figure 4 
                  Baicalein attenuates placental NLRP3 inflammasome activation in GDM mice. The mice were grouped into Control, GDM, GDM + 20 mg/kg Baicalein, and GDM + 40 mg/kg Baicalein. (a) NLRP3 protein expression was analyzed by Western blot. (b) Protein levels of IL-1β and IL-18 were also assessed by Western blot. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001.
Figure 4

Baicalein attenuates placental NLRP3 inflammasome activation in GDM mice. The mice were grouped into Control, GDM, GDM + 20 mg/kg Baicalein, and GDM + 40 mg/kg Baicalein. (a) NLRP3 protein expression was analyzed by Western blot. (b) Protein levels of IL-1β and IL-18 were also assessed by Western blot. Statistical significance: *p < 0.05, **p < 0.01, ***p < 0.001.

4 Discussion

Numerous extracts from Chinese herbs have been shown to influence the progression of gestational diabetes mellitus (GDM). For instance, Polyphyllin I modulates the AMPK pathway to reduce inflammatory damage in GDM [12]. Similarly, Astragaloside IV alleviates placental inflammation and oxidative stress in GDM mice [13], and Resveratrol activates the AMPK pathway to improve GDM progression in mice [14]. Baicalein, a flavonoid with diverse biological functions, has been implicated in the management of various diseases [7,8,9,10]. However, its regulatory roles and mechanisms in the context of GDM have not been fully elucidated. This study demonstrates that Baicalein improves metabolic symptoms in GDM mice by enhancing glucose and insulin tolerance, and normalizing fasting blood glucose and plasma insulin levels. Additionally, Baicalein positively affected reproductive outcomes, including the number of offspring per litter and birth weight.

Inflammation and oxidative stress play pivotal roles in the progression of GDM [15]. Consequently, many researchers have concentrated on modulating these factors to slow the progression of GDM. For instance, cryptotanshinone has been shown to alleviate placental inflammation and oxidative stress in GDM mice [16]. Similarly, N-acetyl-L-cysteine helps reduce both inflammation and oxidative stress associated with GDM [17]. Additionally, miR-875-5p targets TXNRD1, thereby influencing oxidative stress and inflammation in GDM rats [18]. Myrtenol has also been demonstrated to modulate the TLR4/MyD88/NF-κB pathway, thereby mitigating inflammation and oxidative stress in GDM rats [19]. In alignment with these findings, our study observed that inflammation and oxidative stress were elevated in GDM mice. However, these effects were significantly mitigated following treatment with Baicalein (40 mg/kg), suggesting that Baicalein can also effectively alleviate inflammation and oxidative stress in the context of GDM.

Inflammatory factors such as TNF-α, IL-6, and C-reactive protein are known to contribute to insulin resistance in GDM [20]. The nucleotide-binding oligomerization domain-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome, a macromolecular complex consisting of NLRP3, caspase-1, and ASC, plays a critical role in this process [21]. The interaction between caspase-1 and pathogen-associated molecular patterns or damage-associated molecular patterns activates the NLRP3 inflammasome, leading to the secretion of IL-1β and IL-18 from immune cells and promoting inflammation [22]. Previous studies have shown that Baicalein can target the miR-17-5p-Mfn1/2-NF-κB pathway in trophoblast cells, reducing high glucose-induced inflammation and apoptosis [11]. Despite these findings, the effects of Baicalein on the NLRP3 inflammasome in the context of GDM progression in vivo have not been well characterized. In this study, we observed that protein levels of NLRP3, IL-1β, and IL-18 were increased in GDM mice. However, these effects were attenuated following Baicalein treatment, indicating that Baicalein inhibits the NLRP3 inflammasome.

In conclusion, Baicalein effectively inhibited the NLRP3 inflammasome and mitigated placental inflammation and oxidative stress associated with GDM in mice. Nevertheless, this study has certain limitations, including the need for further investigation using human samples, additional cell models, and a broader range of phenotypes. Future research should focus on these areas to provide a more comprehensive understanding of Baicalein’s effects and potential therapeutic applications.


tel: +86-0571-85893328

  1. Funding information: This work was supported by Zhejiang Province Traditional Chinese Medicine Science and Technology Project (Grant No. 2024ZL251).

  2. Author contributions: Yiqi Zhao and Jun Yao designed the study and carried them out; Yiqi Zhao, Jiaying Pan, Qiaoying Jiang, and Hui Wang supervised the data collection, analyzed the data, and interpreted the data; and Yiqi Zhao and Jun Yao prepared the manuscript for publication and reviewed the draft of the manuscript. All authors have read and approved the manuscript.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: Datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Sweeting A, Hannah W, Backman H, Catalano P, Feghali M, Herman WH, et al. Epidemiology and management of gestational diabetes. Lancet. 2024;404(10448):175–92.10.1016/S0140-6736(24)00825-0Search in Google Scholar PubMed

[2] Chatzakis C, Cavoretto P, Sotiriadis A. Gestational diabetes mellitus pharmacological prevention and treatment. Curr Pharm Des. 2021;27(36):3833–40.10.2174/1381612827666210125155428Search in Google Scholar PubMed

[3] Xie J, Li L, Xing H. Metabolomics in gestational diabetes mellitus: A review. Clin Chim Acta. 2023;539:134–43.10.1016/j.cca.2022.12.005Search in Google Scholar PubMed

[4] Will JS, Crellin H. Gestational diabetes mellitus: update on screening, diagnosis, and management. Am Fam Physician. 2023;108(3):249–58.Search in Google Scholar

[5] de Mendonça E, Fragoso MBT, de Oliveira JM, Xavier JA, Goulart MOF, de Oliveira ACM. Gestational diabetes mellitus: the crosslink among inflammation, nitroxidative stress, intestinal microbiota and alternative therapies. Antioxidants (Basel). 2022;11(1):129.10.3390/antiox11010129Search in Google Scholar PubMed PubMed Central

[6] Tuli HS, Aggarwal V, Kaur J, Aggarwal D, Parashar G, Parashar NC, et al. Baicalein: A metabolite with promising antineoplastic activity. Life Sci. 2020;259:118183.10.1016/j.lfs.2020.118183Search in Google Scholar PubMed

[7] Liu BY, Li L, Liu GL, Ding W, Chang WG, Xu T, et al. Baicalein attenuates cardiac hypertrophy in mice via suppressing oxidative stress and activating autophagy in cardiomyocytes. Acta Pharmacol Sin. 2021;42(5):701–14.10.1038/s41401-020-0496-1Search in Google Scholar PubMed PubMed Central

[8] Li M, Meng Z, Yu S, Li J, Wang Y, Yang W, et al. Baicalein ameliorates cerebral ischemia-reperfusion injury by inhibiting ferroptosis via regulating GPX4/ACSL4/ACSL3 axis. Chem Biol Interact. 2022;366:110137.10.1016/j.cbi.2022.110137Search in Google Scholar PubMed

[9] Wang X, Cai H, Chen Z, Zhang Y, Wu M, Xu X, et al. Baicalein alleviates pyroptosis and inflammation in hyperlipidemic pancreatitis by inhibiting NLRP3/Caspase-1 pathway through the miR-192-5p/TXNIP axis. Int Immunopharmacol. 2021;101(Pt B):108315.10.1016/j.intimp.2021.108315Search in Google Scholar PubMed

[10] Li YY, Wang XJ, Su YL, Wang Q, Huang SW, Pan ZF, et al. Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s. Acta Pharmacol Sin. 2022;43(6):1495–507.10.1038/s41401-021-00781-7Search in Google Scholar PubMed PubMed Central

[11] Li J, Wang Y, Wu T, Li S, Sun YN, Liu ZH. Baicalein suppresses high glucose-induced inflammation and apoptosis in trophoblasts by targeting the miRNA-17-5p-Mfn1/2-NF-κB pathway. Placenta. 2022;121:126–36.10.1016/j.placenta.2022.02.013Search in Google Scholar PubMed

[12] Cai Y, Xie F, Wang H, Zhai Q, Lin F, Pan S. Polyphyllin I alleviates inflammatory injury in mice with gestational diabetes through AMPK pathway. Gen Physiol Biophys. 2022;41(2):159–64.10.4149/gpb_2022006Search in Google Scholar PubMed

[13] Zhou L, Zhang R, Yang S, Zhang Y, Shi D. Astragaloside IV alleviates placental oxidative stress and inflammation in GDM mice. Endocr Connect. 2020;9(9):939–45.10.1530/EC-20-0295Search in Google Scholar PubMed PubMed Central

[14] Yao L, Wan J, Li H, Ding J, Wang Y, Wang X, et al. Resveratrol relieves gestational diabetes mellitus in mice through activating AMPK. Reprod Biol Endocrinol. 2015;13:118.10.1186/s12958-015-0114-0Search in Google Scholar PubMed PubMed Central

[15] Saucedo R, Ortega-Camarillo C, Ferreira-Hermosillo A, Díaz-Velázquez MF, Meixueiro-Calderón C, Valencia-Ortega J. Role of oxidative stress and inflammation in gestational diabetes mellitus. Antioxidants (Basel). 2023;12(10):1812.10.3390/antiox12101812Search in Google Scholar PubMed PubMed Central

[16] Wang N, Dong X, Shi D, Li N, Zhang Q. Cryptotanshinone ameliorates placental oxidative stress and inflammation in mice with gestational diabetes mellitus. Arch Pharm Res. 2020;43(7):755–64.10.1007/s12272-020-01242-1Search in Google Scholar PubMed

[17] Xing S, Guo Z, Lang J, Zhou M, Cao J, He H, et al. N-Acetyl-l-cysteine ameliorates gestational diabetes mellitus by inhibiting oxidative stress. Gynecol Endocrinol. 2023;39(1):2189969.10.1080/09513590.2023.2189969Search in Google Scholar PubMed

[18] Fu S, Fu S, Ma X, Yang X, Ling J. miR‑875‑5p regulates IR and inflammation via targeting TXNRD1 in gestational diabetes rats. Mol Med Rep. 2021;23(5):303.10.3892/mmr.2021.11942Search in Google Scholar PubMed PubMed Central

[19] Xuemei L, Qiu S, Chen G, Liu M. Myrtenol alleviates oxidative stress and inflammation in diabetic pregnant rats via TLR4/MyD88/NF-κB signaling pathway. J Biochem Mol Toxicol. 2021;35(11):e22904.10.1002/jbt.22904Search in Google Scholar PubMed

[20] Gayatri V, Krishna Prasad M, Mohandas S, Nagarajan S, Kumaran K, Ramkumar KM. Crosstalk between inflammasomes, inflammation, and Nrf2: Implications for gestational diabetes mellitus pathogenesis and therapeutics. Eur J Pharmacol. 2024;963:176241.10.1016/j.ejphar.2023.176241Search in Google Scholar PubMed

[21] Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18(9):2114–27.10.1038/s41423-021-00740-6Search in Google Scholar PubMed PubMed Central

[22] Yang Y, Wang H, Kouadir M, Song H, Shi F. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis. 2019;10(2):128.10.1038/s41419-019-1413-8Search in Google Scholar PubMed PubMed Central

Received: 2024-06-06
Revised: 2024-08-15
Accepted: 2024-08-19
Published Online: 2024-12-31

© 2024 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Constitutive and evoked release of ATP in adult mouse olfactory epithelium
  3. LARP1 knockdown inhibits cultured gastric carcinoma cell cycle progression and metastatic behavior
  4. PEGylated porcine–human recombinant uricase: A novel fusion protein with improved efficacy and safety for the treatment of hyperuricemia and renal complications
  5. Research progress on ocular complications caused by type 2 diabetes mellitus and the function of tears and blepharons
  6. The role and mechanism of esketamine in preventing and treating remifentanil-induced hyperalgesia based on the NMDA receptor–CaMKII pathway
  7. Brucella infection combined with Nocardia infection: A case report and literature review
  8. Detection of serum interleukin-18 level and neutrophil/lymphocyte ratio in patients with antineutrophil cytoplasmic antibody-associated vasculitis and its clinical significance
  9. Ang-1, Ang-2, and Tie2 are diagnostic biomarkers for Henoch-Schönlein purpura and pediatric-onset systemic lupus erythematous
  10. PTTG1 induces pancreatic cancer cell proliferation and promotes aerobic glycolysis by regulating c-myc
  11. Role of serum B-cell-activating factor and interleukin-17 as biomarkers in the classification of interstitial pneumonia with autoimmune features
  12. Effectiveness and safety of a mumps containing vaccine in preventing laboratory-confirmed mumps cases from 2002 to 2017: A meta-analysis
  13. Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms
  14. A case of Trousseau syndrome: Screening, detection and complication
  15. Application of the integrated airway humidification device enhances the humidification effect of the rabbit tracheotomy model
  16. Preparation of Cu2+/TA/HAP composite coating with anti-bacterial and osteogenic potential on 3D-printed porous Ti alloy scaffolds for orthopedic applications
  17. Aquaporin-8 promotes human dermal fibroblasts to counteract hydrogen peroxide-induced oxidative damage: A novel target for management of skin aging
  18. Current research and evidence gaps on placental development in iron deficiency anemia
  19. Single-nucleotide polymorphism rs2910829 in PDE4D is related to stroke susceptibility in Chinese populations: The results of a meta-analysis
  20. Pheochromocytoma-induced myocardial infarction: A case report
  21. Kaempferol regulates apoptosis and migration of neural stem cells to attenuate cerebral infarction by O‐GlcNAcylation of β-catenin
  22. Sirtuin 5 regulates acute myeloid leukemia cell viability and apoptosis by succinylation modification of glycine decarboxylase
  23. Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner
  24. KAT2A changes the function of endometrial stromal cells via regulating the succinylation of ENO1
  25. Current state of research on copper complexes in the treatment of breast cancer
  26. Exploring antioxidant strategies in the pathogenesis of ALS
  27. Helicobacter pylori causes gastric dysbacteriosis in chronic gastritis patients
  28. IL-33/soluble ST2 axis is associated with radiation-induced cardiac injury
  29. The predictive value of serum NLR, SII, and OPNI for lymph node metastasis in breast cancer patients with internal mammary lymph nodes after thoracoscopic surgery
  30. Carrying SNP rs17506395 (T > G) in TP63 gene and CCR5Δ32 mutation associated with the occurrence of breast cancer in Burkina Faso
  31. P2X7 receptor: A receptor closely linked with sepsis-associated encephalopathy
  32. Probiotics for inflammatory bowel disease: Is there sufficient evidence?
  33. Identification of KDM4C as a gene conferring drug resistance in multiple myeloma
  34. Microbial perspective on the skin–gut axis and atopic dermatitis
  35. Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery
  36. Highly specific vaginal microbiome signature for gynecological cancers
  37. Sample size estimation for AQP4-IgG seropositive optic neuritis: Retinal damage detection by optical coherence tomography
  38. The effects of SDF-1 combined application with VEGF on femoral distraction osteogenesis in rats
  39. Fabrication and characterization of gold nanoparticles using alginate: In vitro and in vivo assessment of its administration effects with swimming exercise on diabetic rats
  40. Mitigating digestive disorders: Action mechanisms of Mediterranean herbal active compounds
  41. Distribution of CYP2D6 and CYP2C19 gene polymorphisms in Han and Uygur populations with breast cancer in Xinjiang, China
  42. VSP-2 attenuates secretion of inflammatory cytokines induced by LPS in BV2 cells by mediating the PPARγ/NF-κB signaling pathway
  43. Factors influencing spontaneous hypothermia after emergency trauma and the construction of a predictive model
  44. Long-term administration of morphine specifically alters the level of protein expression in different brain regions and affects the redox state
  45. Application of metagenomic next-generation sequencing technology in the etiological diagnosis of peritoneal dialysis-associated peritonitis
  46. Clinical diagnosis, prevention, and treatment of neurodyspepsia syndrome using intelligent medicine
  47. Case report: Successful bronchoscopic interventional treatment of endobronchial leiomyomas
  48. Preliminary investigation into the genetic etiology of short stature in children through whole exon sequencing of the core family
  49. Cystic adenomyoma of the uterus: Case report and literature review
  50. Mesoporous silica nanoparticles as a drug delivery mechanism
  51. Dynamic changes in autophagy activity in different degrees of pulmonary fibrosis in mice
  52. Vitamin D deficiency and inflammatory markers in type 2 diabetes: Big data insights
  53. Lactate-induced IGF1R protein lactylation promotes proliferation and metabolic reprogramming of lung cancer cells
  54. Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphoma
  55. Mitochondrial DNA drives neuroinflammation through the cGAS-IFN signaling pathway in the spinal cord of neuropathic pain mice
  56. Application value of artificial intelligence algorithm-based magnetic resonance multi-sequence imaging in staging diagnosis of cervical cancer
  57. Embedded monitoring system and teaching of artificial intelligence online drug component recognition
  58. Investigation into the association of FNDC1 and ADAMTS12 gene expression with plumage coloration in Muscovy ducks
  59. Yak meat content in feed and its impact on the growth of rats
  60. A rare case of Richter transformation with breast involvement: A case report and literature review
  61. First report of Nocardia wallacei infection in an immunocompetent patient in Zhejiang province
  62. Rhodococcus equi and Brucella pulmonary mass in immunocompetent: A case report and literature review
  63. Downregulation of RIP3 ameliorates the left ventricular mechanics and function after myocardial infarction via modulating NF-κB/NLRP3 pathway
  64. Evaluation of the role of some non-enzymatic antioxidants among Iraqi patients with non-alcoholic fatty liver disease
  65. The role of Phafin proteins in cell signaling pathways and diseases
  66. Ten-year anemia as initial manifestation of Castleman disease in the abdominal cavity: A case report
  67. Coexistence of hereditary spherocytosis with SPTB P.Trp1150 gene variant and Gilbert syndrome: A case report and literature review
  68. Utilization of convolutional neural networks to analyze microscopic images for high-throughput screening of mesenchymal stem cells
  69. Exploratory evaluation supported by experimental and modeling approaches of Inula viscosa root extract as a potent corrosion inhibitor for mild steel in a 1 M HCl solution
  70. Imaging manifestations of ductal adenoma of the breast: A case report
  71. Gut microbiota and sleep: Interaction mechanisms and therapeutic prospects
  72. Isomangiferin promotes the migration and osteogenic differentiation of rat bone marrow mesenchymal stem cells
  73. Prognostic value and microenvironmental crosstalk of exosome-related signatures in human epidermal growth factor receptor 2 positive breast cancer
  74. Circular RNAs as potential biomarkers for male severe sepsis
  75. Knockdown of Stanniocalcin-1 inhibits growth and glycolysis in oral squamous cell carcinoma cells
  76. The expression and biological role of complement C1s in esophageal squamous cell carcinoma
  77. A novel GNAS mutation in pseudohypoparathyroidism type 1a with articular flexion deformity: A case report
  78. Predictive value of serum magnesium levels for prognosis in patients with non-small cell lung cancer undergoing EGFR-TKI therapy
  79. HSPB1 alleviates acute-on-chronic liver failure via the P53/Bax pathway
  80. IgG4-related disease complicated by PLA2R-associated membranous nephropathy: A case report
  81. Baculovirus-mediated endostatin and angiostatin activation of autophagy through the AMPK/AKT/mTOR pathway inhibits angiogenesis in hepatocellular carcinoma
  82. Metformin mitigates osteoarthritis progression by modulating the PI3K/AKT/mTOR signaling pathway and enhancing chondrocyte autophagy
  83. Evaluation of the activity of antimicrobial peptides against bacterial vaginosis
  84. Atypical presentation of γ/δ mycosis fungoides with an unusual phenotype and SOCS1 mutation
  85. Analysis of the microecological mechanism of diabetic kidney disease based on the theory of “gut–kidney axis”: A systematic review
  86. Omega-3 fatty acids prevent gestational diabetes mellitus via modulation of lipid metabolism
  87. Refractory hypertension complicated with Turner syndrome: A case report
  88. Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
  89. Association of low attenuation area scores with pulmonary function and clinical prognosis in patients with chronic obstructive pulmonary disease
  90. Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects
  91. The deubiquitinating enzyme USP35 regulates the stability of NRF2 protein
  92. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential diagnostic markers for rebleeding in patients with esophagogastric variceal bleeding
  93. G protein-coupled receptor 1 participating in the mechanism of mediating gestational diabetes mellitus by phosphorylating the AKT pathway
  94. LL37-mtDNA regulates viability, apoptosis, inflammation, and autophagy in lipopolysaccharide-treated RLE-6TN cells by targeting Hsp90aa1
  95. The analgesic effect of paeoniflorin: A focused review
  96. Chemical composition’s effect on Solanum nigrum Linn.’s antioxidant capacity and erythrocyte protection: Bioactive components and molecular docking analysis
  97. Knockdown of HCK promotes HREC cell viability and inner blood–retinal barrier integrity by regulating the AMPK signaling pathway
  98. The role of rapamycin in the PINK1/Parkin signaling pathway in mitophagy in podocytes
  99. Laryngeal non-Hodgkin lymphoma: Report of four cases and review of the literature
  100. Clinical value of macrogenome next-generation sequencing on infections
  101. Overview of dendritic cells and related pathways in autoimmune uveitis
  102. TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4/CaMKII/NLRP3 pathway
  103. Hypomethylation in promoters of PGC-1α involved in exercise-driven skeletal muscular alterations in old age
  104. Profile and antimicrobial susceptibility patterns of bacteria isolated from effluents of Kolladiba and Debark hospitals
  105. The expression and clinical significance of syncytin-1 in serum exosomes of hepatocellular carcinoma patients
  106. A histomorphometric study to evaluate the therapeutic effects of biosynthesized silver nanoparticles on the kidneys infected with Plasmodium chabaudi
  107. PGRMC1 and PAQR4 are promising molecular targets for a rare subtype of ovarian cancer
  108. Analysis of MDA, SOD, TAOC, MNCV, SNCV, and TSS scores in patients with diabetes peripheral neuropathy
  109. SLIT3 deficiency promotes non-small cell lung cancer progression by modulating UBE2C/WNT signaling
  110. The relationship between TMCO1 and CALR in the pathological characteristics of prostate cancer and its effect on the metastasis of prostate cancer cells
  111. Heterogeneous nuclear ribonucleoprotein K is a potential target for enhancing the chemosensitivity of nasopharyngeal carcinoma
  112. PHB2 alleviates retinal pigment epithelium cell fibrosis by suppressing the AGE–RAGE pathway
  113. Anti-γ-aminobutyric acid-B receptor autoimmune encephalitis with syncope as the initial symptom: Case report and literature review
  114. Comparative analysis of chloroplast genome of Lonicera japonica cv. Damaohua
  115. Human umbilical cord mesenchymal stem cells regulate glutathione metabolism depending on the ERK–Nrf2–HO-1 signal pathway to repair phosphoramide mustard-induced ovarian cancer cells
  116. Electroacupuncture on GB acupoints improves osteoporosis via the estradiol–PI3K–Akt signaling pathway
  117. Renalase protects against podocyte injury by inhibiting oxidative stress and apoptosis in diabetic nephropathy
  118. Review: Dicranostigma leptopodum: A peculiar plant of Papaveraceae
  119. Combination effect of flavonoids attenuates lung cancer cell proliferation by inhibiting the STAT3 and FAK signaling pathway
  120. Renal microangiopathy and immune complex glomerulonephritis induced by anti-tumour agents: A case report
  121. Correlation analysis of AVPR1a and AVPR2 with abnormal water and sodium and potassium metabolism in rats
  122. Gastrointestinal health anti-diarrheal mixture relieves spleen deficiency-induced diarrhea through regulating gut microbiota
  123. Myriad factors and pathways influencing tumor radiotherapy resistance
  124. Exploring the effects of culture conditions on Yapsin (YPS) gene expression in Nakaseomyces glabratus
  125. Screening of prognostic core genes based on cell–cell interaction in the peripheral blood of patients with sepsis
  126. Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management
  127. Ileocecal mucinous carcinoma misdiagnosed as incarcerated hernia: A case report
  128. Methyltransferase like 13 promotes malignant behaviors of bladder cancer cells through targeting PI3K/ATK signaling pathway
  129. The debate between electricity and heat, efficacy and safety of irreversible electroporation and radiofrequency ablation in the treatment of liver cancer: A meta-analysis
  130. ZAG promotes colorectal cancer cell proliferation and epithelial–mesenchymal transition by promoting lipid synthesis
  131. Baicalein inhibits NLRP3 inflammasome activation and mitigates placental inflammation and oxidative stress in gestational diabetes mellitus
  132. Impact of SWCNT-conjugated senna leaf extract on breast cancer cells: A potential apoptotic therapeutic strategy
  133. MFAP5 inhibits the malignant progression of endometrial cancer cells in vitro
  134. Major ozonated autohemotherapy promoted functional recovery following spinal cord injury in adult rats via the inhibition of oxidative stress and inflammation
  135. Axodendritic targeting of TAU and MAP2 and microtubule polarization in iPSC-derived versus SH-SY5Y-derived human neurons
  136. Differential expression of phosphoinositide 3-kinase/protein kinase B and Toll-like receptor/nuclear factor kappa B signaling pathways in experimental obesity Wistar rat model
  137. The therapeutic potential of targeting Oncostatin M and the interleukin-6 family in retinal diseases: A comprehensive review
  138. BA inhibits LPS-stimulated inflammatory response and apoptosis in human middle ear epithelial cells by regulating the Nf-Kb/Iκbα axis
  139. Role of circRMRP and circRPL27 in chronic obstructive pulmonary disease
  140. Investigating the role of hyperexpressed HCN1 in inducing myocardial infarction through activation of the NF-κB signaling pathway
  141. Characterization of phenolic compounds and evaluation of anti-diabetic potential in Cannabis sativa L. seeds: In vivo, in vitro, and in silico studies
  142. Quantitative immunohistochemistry analysis of breast Ki67 based on artificial intelligence
  143. Ecology and Environmental Science
  144. Screening of different growth conditions of Bacillus subtilis isolated from membrane-less microbial fuel cell toward antimicrobial activity profiling
  145. Degradation of a mixture of 13 polycyclic aromatic hydrocarbons by commercial effective microorganisms
  146. Evaluation of the impact of two citrus plants on the variation of Panonychus citri (Acari: Tetranychidae) and beneficial phytoseiid mites
  147. Prediction of present and future distribution areas of Juniperus drupacea Labill and determination of ethnobotany properties in Antalya Province, Türkiye
  148. Population genetics of Todarodes pacificus (Cephalopoda: Ommastrephidae) in the northwest Pacific Ocean via GBS sequencing
  149. A comparative analysis of dendrometric, macromorphological, and micromorphological characteristics of Pistacia atlantica subsp. atlantica and Pistacia terebinthus in the middle Atlas region of Morocco
  150. Macrofungal sporocarp community in the lichen Scots pine forests
  151. Assessing the proximate compositions of indigenous forage species in Yemen’s pastoral rangelands
  152. Food Science
  153. Gut microbiota changes associated with low-carbohydrate diet intervention for obesity
  154. Reexamination of Aspergillus cristatus phylogeny in dark tea: Characteristics of the mitochondrial genome
  155. Differences in the flavonoid composition of the leaves, fruits, and branches of mulberry are distinguished based on a plant metabolomics approach
  156. Investigating the impact of wet rendering (solventless method) on PUFA-rich oil from catfish (Clarias magur) viscera
  157. Non-linear associations between cardiovascular metabolic indices and metabolic-associated fatty liver disease: A cross-sectional study in the US population (2017–2020)
  158. Knockdown of USP7 alleviates atherosclerosis in ApoE-deficient mice by regulating EZH2 expression
  159. Utility of dairy microbiome as a tool for authentication and traceability
  160. Agriculture
  161. Enhancing faba bean (Vicia faba L.) productivity through establishing the area-specific fertilizer rate recommendation in southwest Ethiopia
  162. Impact of novel herbicide based on synthetic auxins and ALS inhibitor on weed control
  163. Perspectives of pteridophytes microbiome for bioremediation in agricultural applications
  164. Fertilizer application parameters for drip-irrigated peanut based on the fertilizer effect function established from a “3414” field trial
  165. Improving the productivity and profitability of maize (Zea mays L.) using optimum blended inorganic fertilization
  166. Application of leaf multispectral analyzer in comparison to hyperspectral device to assess the diversity of spectral reflectance indices in wheat genotypes
  167. Animal Sciences
  168. Knockdown of ANP32E inhibits colorectal cancer cell growth and glycolysis by regulating the AKT/mTOR pathway
  169. Development of a detection chip for major pathogenic drug-resistant genes and drug targets in bovine respiratory system diseases
  170. Exploration of the genetic influence of MYOT and MB genes on the plumage coloration of Muscovy ducks
  171. Transcriptome analysis of adipose tissue in grazing cattle: Identifying key regulators of fat metabolism
  172. Comparison of nutritional value of the wild and cultivated spiny loaches at three growth stages
  173. Transcriptomic analysis of liver immune response in Chinese spiny frog (Quasipaa spinosa) infected with Proteus mirabilis
  174. Disruption of BCAA degradation is a critical characteristic of diabetic cardiomyopathy revealed by integrated transcriptome and metabolome analysis
  175. Plant Sciences
  176. Effect of long-term in-row branch covering on soil microorganisms in pear orchards
  177. Photosynthetic physiological characteristics, growth performance, and element concentrations reveal the calcicole–calcifuge behaviors of three Camellia species
  178. Transcriptome analysis reveals the mechanism of NaHCO3 promoting tobacco leaf maturation
  179. Bioinformatics, expression analysis, and functional verification of allene oxide synthase gene HvnAOS1 and HvnAOS2 in qingke
  180. Water, nitrogen, and phosphorus coupling improves gray jujube fruit quality and yield
  181. Improving grape fruit quality through soil conditioner: Insights from RNA-seq analysis of Cabernet Sauvignon roots
  182. Role of Embinin in the reabsorption of nucleus pulposus in lumbar disc herniation: Promotion of nucleus pulposus neovascularization and apoptosis of nucleus pulposus cells
  183. Revealing the effects of amino acid, organic acid, and phytohormones on the germination of tomato seeds under salinity stress
  184. Combined effects of nitrogen fertilizer and biochar on the growth, yield, and quality of pepper
  185. Comprehensive phytochemical and toxicological analysis of Chenopodium ambrosioides (L.) fractions
  186. Impact of “3414” fertilization on the yield and quality of greenhouse tomatoes
  187. Exploring the coupling mode of water and fertilizer for improving growth, fruit quality, and yield of the pear in the arid region
  188. Metagenomic analysis of endophytic bacteria in seed potato (Solanum tuberosum)
  189. Antibacterial, antifungal, and phytochemical properties of Salsola kali ethanolic extract
  190. Exploring the hepatoprotective properties of citronellol: In vitro and in silico studies on ethanol-induced damage in HepG2 cells
  191. Enhanced osmotic dehydration of watermelon rind using honey–sucrose solutions: A study on pre-treatment efficacy and mass transfer kinetics
  192. Effects of exogenous 2,4-epibrassinolide on photosynthetic traits of 53 cowpea varieties under NaCl stress
  193. Comparative transcriptome analysis of maize (Zea mays L.) seedlings in response to copper stress
  194. An optimization method for measuring the stomata in cassava (Manihot esculenta Crantz) under multiple abiotic stresses
  195. Fosinopril inhibits Ang II-induced VSMC proliferation, phenotype transformation, migration, and oxidative stress through the TGF-β1/Smad signaling pathway
  196. Antioxidant and antimicrobial activities of Salsola imbricata methanolic extract and its phytochemical characterization
  197. Bioengineering and Biotechnology
  198. Absorbable calcium and phosphorus bioactive membranes promote bone marrow mesenchymal stem cells osteogenic differentiation for bone regeneration
  199. New advances in protein engineering for industrial applications: Key takeaways
  200. An overview of the production and use of Bacillus thuringiensis toxin
  201. Research progress of nanoparticles in diagnosis and treatment of hepatocellular carcinoma
  202. Bioelectrochemical biosensors for water quality assessment and wastewater monitoring
  203. PEI/MMNs@LNA-542 nanoparticles alleviate ICU-acquired weakness through targeted autophagy inhibition and mitochondrial protection
  204. Unleashing of cytotoxic effects of thymoquinone-bovine serum albumin nanoparticles on A549 lung cancer cells
  205. Erratum
  206. Erratum to “Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM”
  207. Erratum to “Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation”
  208. Retraction
  209. Retraction to “MiR-223-3p regulates cell viability, migration, invasion, and apoptosis of non-small cell lung cancer cells by targeting RHOB”
  210. Retraction to “A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis”
  211. Special Issue on Advances in Neurodegenerative Disease Research and Treatment
  212. Transplantation of human neural stem cell prevents symptomatic motor behavior disability in a rat model of Parkinson’s disease
  213. Special Issue on Multi-omics
  214. Inflammasome complex genes with clinical relevance suggest potential as therapeutic targets for anti-tumor drugs in clear cell renal cell carcinoma
  215. Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?
Downloaded on 24.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0966/html
Scroll to top button